Treatment

DR-01 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
This study is testing a new medicine called DR-01 for people with certain types of blood cancers, specifically Large Granular Lymphocytic Leukemia (LGLL) and various cytotoxic lymphomas. It aims to see if DR-01 is safe, well-tolerated, and effective in shrinking these cancers.
For: LGLL - Large Granular Lymphocytic Leukemia · Primary Cutaneous Gamma-Delta T-Cell Lymphoma · Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma
United States · Australia · France